Neospora caninum negatively impacts bovine reproductive performance around the world. Addressing this problem requires a greater understanding of the parasite's molecular biology. In this study, monoclonal antibodies against recombinant proteins were successfully developed and employed to characterise two different proteins of N. caninum: the acute phase-associated NcGRA7 and the chronic phase-associated NcSAG4. Immunofluorescence with the anti-rNcGRA7 monoclonal antibody suggested that NcGRA7 trafficks from tachyzoite dense granules to the matrix of the parasitophorous vacuole and parasite's surroundings. Furthermore, NcGRA7 is also expressed in the bradyzoite stage and localised on the matrix of bradyzoite-positive vacuoles. NcGRA7 appears to be partially involved in the tachyzoite-invasion mechanisms, as an anti-rNcGRA7 monoclonal antibody partially inhibited in vitro tachyzoite-invasion. A monoclonal antibody specific for NcSAG4 confirmed this protein's bradyzoitespecific expression both by western blot and immunofluorescence. However, some bradyzoite-positive vacuoles only weakly expressed NcSAG4, if it was expressed at all. The specificity of the anti-rNcSAG4 monoclonal antibody was confirmed by the recognition of the NcSAG4 in the membrane surface of Nc-1SAG4 c transgenic tachyzoites, which constitutively expresses NcSAG4. Blocking NcSAG4 of Nc-1SAG4 c tachyzoites with the monoclonal antibody did not affect host cell invasion. However, its implication on the host cell adhesion or host immune evasion should not be discarded.
Introduction
Neospora caninum is an obligate intracellular, cyst-forming coccidium, closely related to T. gondii. It is a major cause of reproductive failure in cattle (Dubey et al. 2007 ) and negatively affects the economic performance in herds (Reichel and Ellis 2006) .
The knowledge of the cellular and molecular biology of this protozoan with regard to interactions with the host cell represents the basis of new diagnostic tools and immuno-or chemotherapy targets against neosporosis (Hemphill 1999, Dubey and Schares 2006) . Modern research is mainly based on the mechanisms and antigens involved in the tachyzoite adhesion, invasion and its proliferation and persistence in the host cell. Thus, elucidating the relationship between these proteins and the host immune response will help to design effective vaccines that inhibit the parasite's proliferation (Reichel and Ellis 2009) . The relevant role of GRA proteins in the closely related T. gondii is well known: GRA proteins constitute a highly immunogenic group which are excreted/secreted by dense granules to the parasitophorous vacuole during parasite intracellular development (Cesbron-Delauw 1994) . In particular, GRA7 is a highly immunogenic, dense granule protein in both T. gondii and N. caninum (Lally et al. 1997 , Fischer et al. 1998 , Vonlaufen et al. 2004 , which has been effectively employed as a diagnostic tool (Aguado-Martínez et al. 2008) . Moreover, although GRA proteins appear to be related to intracellular parasite development, previous studies *Corresponding author: gemaga@vet.ucm.es Characterisation of Neospora caninum NcGRA7 and NcSAG4 proteins 305 revealed that NcGRA7 might be involved in the initial host cell invasion process of N. caninum (Augustine et al. 1999 , Cho et al. 2005 .
Regarding parasite persistence in tissue cysts containing the quiescent bradyzoite stage, like T. gondii, N. caninum modifies its surface antigenic composition, expressing proteins of the SAG1-related sequence superfamily when during conversion from tachyzoite to bradyzoite. This phenomenon constitutes a very efficient mechanism to evade the immune system, allowing the protozoan to persist in the host for many years. Until now, two bradyzoite-specific proteins of N. caninum have been identified and cloned: NcSAG4 (Fernández-García et al. 2006) and NcBSR4 (Risco-Castillo et al. 2007) . NcSAG4 is expressed early during the process of stage conversion (Fernández-García et al. 2006) and has been shown to be a reliable marker for chronic infection (Aguado-Martínez et al. 2008 , 2009b . Moreover, antibodies against the T. gondii bradyzoite antigen 1 (TgBAG1), specifically expressed in this stage (Bohne et al. 1995) , cross-react with N. caninum tissue cysts and bradyzoites obtained in vivo and in vitro, respectively (Weiss et al. 1999) suggesting that an orthologous protein exists in this parasite.
The objective of the present study was to characterise the N. caninum immunogenic, dense granule NcGRA7 protein and the bradyzoite-specific NcSAG4 protein in vitro. For this purpose, the host cell immunolocalisation and stage-specificity of both proteins were studied by western blot and immunofluorescence. Cross-reactivities with the closely-related T. gondii were also examined. In addition, the role of both proteins in the host cell invasion by tachyzoites was investigated through in vitro invasion inhibition assays. All assays were conducted with monoclonal antibodies (MABs) obtained against the recombinant proteins rNcGRA7 and rNcSAG4.
Materials and methods

Parasites
Neospora caninum tachyzoites of the Nc-Liv strain (Barber et al. 1993) or the Nc-1SAG4 c mutant strain (Marugán-Hernán-dez et al. submitted) were maintained in vitro by continuous passage in MARC-145 cells and Dulbecco's Modified Eagle Medium (DMEM) medium using standard procedures described previously (Pérez-Zaballos et al. 2005) . T. gondii tachyzoites of the ME-49 strain were maintained in vitro by continuous passage in human fibroblast cells and RPMI medium supplemented with penicillin, streptomycin, HEPES (50 mM) and 5% foetal bovine serum (FBS) . N. caninum bradyzoites were obtained by treating tachyzoite-infected cultures with 70 µM sodium nitroprusside, as previously described (Risco-Castillo et al. 2004) . T. gondii bradyzoites were obtained by increasing the pH of the medium to 8.2 with 1 N NaOH four hours after invasion and initial growth of the parasite in the cell culture (Boothroyd et al. 1997) . N. caninum and T. gondii tachyzoites or bradyzoites were harvested from tissue culture, washed with cold sterile phosphate-buffered saline (PBS) pH 7.2, purified by disposable PD-10 desalting columns (GE Healthcare, Buckinghamshire, UK), counted by Trypan blue vital dye exclusion, pelleted and stored at -80°C until use in western blots.
Recombinant proteins
Both rNcGRA7 and rNcSAG4 were cloned into the prokaryotic expression vector pRSET-C (Invitrogen) and expressed as polyhistidine-tagged fusion proteins in Escherichia coli (Fernández-García et al. 2006 . Protein extraction and purification was performed as previously described (Aguado-Martínez et al. 2008) . The concentration and purity of both recombinant proteins was checked by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) with a standard BSA scale (Roche) and by western blot using a monoclonal anti-T7 tag antibody (Novagen) and polyclonal anti-rNcGRA7 and rNcSAG4 mouse sera (Fernández-García et al. 2006 , Aguado-Martínez et al. 2008 .
Monoclonal antibody production
MABs against rNcGRA7 and rNcSAG4 were obtained using a previously reported procedure (Schares et al. 1999) . Briefly, BALB/c mice were immunised with rNcGRA7 or rNcSAG4 following standard procedures. Next, mice were daily boosted with 50 ng of proteins by intravenous injection in the tail vein in the three days prior to euthanasia. Once mice were euthanized, splenocytes were fused with SP2/0 myeloma cells. The supernatants of the resulting hybridomas were screened for antibodies against rNcGRA7 or rNcSAG4 by western blot. Positive hybridomas were cloned by limiting dilution and recloned at least twice. The clone's isotype was determined using a commercial isotyping kit (Serotec, Oxford, UK). Among several positive hybridoma clones, two anti-rNcGRA7 and A9/12-12 [IgG2a]) and one anti-rNc-SAG4 (8/1-10 [IgG1]) were selected. Clones were successfully maintained by continuous passage in serum free NEPHROS-LP medium (bioWhittaker) supplemented with 1% L-glutamine, non-essential amino acids, and vitamins (Biochrom). MABs were purified and concentrated from hybridoma culture supernatant by affinity chromatography in protein A-sepharose columns (GE Healthcare) and recovered in a final MAB buffer containing 0.1 M PBS-Tris/HCl, 0.1 M glycine. Purity of MABs was confirmed by SDS-PAGE and concentration was measured by spectrophotometry.
Immunofluorescence
Immunofluorescence was carried out on 12 mm-coverslips of monolayer cellular culture infected with N. caninum or T. gondii tachyzoites and/or bradyzoites and fixed with PBS containing 3% paraformaldehyde and 0.05% glutaraldehyde for 10-15 min at room temperature. After fixation, cultures were immediately washed three times with PBS. Fixed cultures were blocked and permeabilised with PBS containing 3% bovine serum albumin and 0.25% Triton X-100 for 30 min at room temperature. Cultures were incubated with MABs at different dilutions (1:50, 1:100 and 1:500) for 1 h at 37°C. Following three washes with PBS, coverslips were incubated with Alexa Fluor 488-conjugated goat anti-mouse IgG (1:1000) (Invitrogen, Carlsbad, CA, USA) for 1 h at 37°C. In the case of immunofluorescence of tachyzoite/bradyzoite-infected culture, a double-labelling was carried out in order to identify bradyzoite stages. This included incubation with polyclonal rabbit anti-serum developed against the intracytoplasmic bradyzoite-specific antigen BAG1 (1:500) (McAllister et al. 1996) , or with Dolichos biflorus lectin (DBL) for 1 h at 37°C, followed by three washes with PBS and incubation with the appropriate Alexa Fluor 594-conjugated goat anti-rabbit IgG (1:1,000) (Invitrogen, Carlsbad, CA, USA) for 1 h at 37°C. Coverslips were washed three times with PBS and once with distilled water and mounted on a glass slide with medium containing 45.5% glycerol and 2.3% 1,4-diazabicyclo[2.2.2] octane (DABCO) (Sigma, St. Louis, MO, USA). Photographs were taken using a digital camera (Nikon Digital Sight DS-L1) connected to an inverted fluorescence microscope (model TE200 Nikon) using a 100X oil-immersion objective.
SDS-PAGE and western blot
Neospora caninum or T. gondii tachyzoites or bradyzoites (2 × 10 6 and 10 6 , respectively) were disrupted in Laemmli buffer without mercaptoethanol by sonication, electrophoresed in 12.5% polyacrylamide gels under non-reducing conditions and transferred onto polyvinylidene difluoride membranes according to standard procedures (Schares et al. 1999) . Western blotting was carried out by incubating membranes with undiluted hybridoma supernatants or purified MABs at dilutions of 1:25, 1:50 or 1:100 followed by anti-mouse IgG antibody conjugated to peroxidase (Sigma, St. Louis, MO, USA) (1:5,000) and developed using the Supersignal chemiluminescence system (Pierce, Rockford, IL, USA).
To examine recombinant proteins, 20 µg of rNcSAG4 or rNcGRA7 were subjected to gel electrophoresis under reducing conditions and transferred onto polyvinylidene difluoride membranes. Western blotting was performed as described above until visualisation with 4-chloro-1-naphthol substrate (Sigma).
Invasion inhibition assays
To assess the inhibitory effect of the anti-rNcGRA7 (A1/24-12 clone) and the anti-rNcSAG4 (8/1-10) MABs on host-cell invasion by N. caninum tachyzoites, the Nc-Liv and an Nc-1SAG4 c transgenic strain were employed using a procedure partially based on Hemphill et al. (1996) . MARC-145 cells were grown on 12 mm coverslips in 24-well tissue culture plates (5 × 10 4 cells per coverslip). After 24 h, N. caninum tachyzoites were purified from cellular culture and incubated for 30 min at 37°C in the presence of one of the following additives: rabbit hyperimmune anti-N. caninum tachyzoite serum (1:50), rabbit pre-immune serum (1:50), anti-rNcGRA7 or anti-rNcSAG4 MABs (20 µg/ml), non-specific MAB (at same concentration), MAB buffer and culture medium alone (nontreated tachyzoites as control). Rabbit hyperimmune serum was obtained by immunising two three-month-old New Zealand rabbits with 10 8 N. caninum tachyzoites emulsified with Complete Freund's Adjuvant following previous recommendations (Vaitukaitis 1981) . After incubation with each additive, cell monolayers were infected with the pre-treated tachyzoites at an MOI of 2:1 and incubated for four hours at 37°C with 5% CO 2 to allow tachyzoites to invade host cells. Unbound parasites were removed by washing three times with PBS and coverslips were fixed with PBS containing 3% paraformaldehyde and 0.05% glutaraldehyde. Invasion rate was estimated by double immunofluorescence. After blocking, coverslips were incubated with a rabbit anti-N. caninum tachyzoite hyperimmune serum (1:4,000) followed by incubation with goat anti-rabbit IgG Alexa Fluor 594 (1:1,000). Parasites were permeabilised with PBS, 3% BSA, 0.25% Triton X-100, and incubated again with the same primary antibody followed by Alexa Fluor 488 (1:1,000). Coverslips were mounted as described above. Each treatment was tested in triplicate, and each experiment was repeated three times. Coverslips were examined by inverted fluorescence microscope and extracellular and invading tachyzoites were counted in 15 fields per coverslip. To determine the invasion percentage the following formula was applied to each coverslip: Invasion % = [(no invading tachyzoites × 100)/no total tachyzoites]. An average of invasion % was calculated among the three triplicates from each treatment. The inhibition % was calculated as: Inhibition % = [(invasion % of non-treated tachyzoitesinvasion % of treated tachyzoites) × 100/invasion % of nontreated tachyzoites.
Data analysis
Data from invasion inhibition assays were compared by Chisquare analysis. All pair-wise comparisons were analysed by Fisher's exact test and Bonferroni's adjustment was applied to the P value using the formula [0.05/k × (k-1)/2] where k corresponds to the number of groups.
Results
Stage-specificity and cellular localisation of NcGRA7 and NcSAG4
Both anti-rNcGRA7 hybridoma clones (A1/24-12 and A9/12-12) intensely recognised rNcGRA7 (Fig. 1, panel A) . After purification, the MAB reaction against rNcGRA7 was maintained until a dilution 1:500 (data not shown). Both A1/24-12 and A9/12-12 MABs also recognised a band of 33 kDa in both tachyzoite and tachyzoite/bradyzoite extracts by western blotting (Fig. 1, panel B) . The same band of 33 kDa was also recognised by the MAB 4.11.5 previously described by Schares et al. (1999) . Interestingly, the MAB A1/24-12, but not the A9/12-12, also recognised another 29 kDa band in both tachyzoite and tachyzoite/bradyzoite extracts (Fig. 1, panel B) . Concerning cellular immunolocalisation of native NcGRA7 in N. caninum-infected cells, both anti-rNcGRA7 MABs intensely labelled the cytoplasm content in the tachyzoites (Fig.  2C ). In the case of tachyzoites within a developed parasitophorous vacuole, the MABs bound to the tachyzoite surroundings and intensely to the vacuolar matrix ( Fig. 2A, B and D). Both anti-rNcGRA7 MABs bound with a similar pattern to parasitophorous vacuoles of N. caninum with a Dolichos biflorus-positive staining, i.e. after stage conversion from tachyzoite to bradyzoite ( Fig. 2E and F) . No difference in pattern was observed between the two anti-rNcGRA7 MAB clones using immunofluorescence. None of the anti-rNcGRA7 MABs reacted with T. gondii tachyzoite or bradyzoite either by western blot or immunofluorescence (data not shown).
More than ten hybridoma clones that recognised recombinant rNcSAG4 were initially checked by immunofluorescence on N. caninum tachyzoite/bradyzoite-infected culture, but only clone 8/1-10 specifically reacted against N. caninum as BAG1 positive, i.e. bradyzoite containing parasitophorous vacuoles (data not shown). This clone was purified and its reaction against recombinant rNcSAG4 (Fig. 1, panel A) was conserved until a dilution 1:500 was used. In western blots with tachyzoite/bradyzoite extract, but not in those with a tachyzoite extract, MAB 8/1-10 stained a 15-16 kDa band (Fig. 1,  panel B) . NcSAG4 was predominantly localised on the bradyzoite surface membrane by immunofluorescence in the tachyzoite/bradyzoite-infected culture, although the signal was weak (data not shown). To confirm the reactivity of anti-rNcSAG4 MAB, immunofluorescence on a N. caninum transgenic isolate that constitutively expresses NcSAG4 at the tachyzoite stage (Nc-1SAG4 c ) (Marugán-Hernández et al. submitted), (2), anti-rNcSAG4 MAB clone 8/1-10 (4) and medium control (3) was performed. MAB 8/1-10 reacted with the surface membrane of Nc-1SAG4 c tachyzoites (Fig. 2G) . No cross-reactivity was detected against T. gondii bradyzoites by either western blot or immunofluorescence (data not shown).
Invasion inhibition assays by MABs
Appropriate dilutions of hyperimmune anti-N. caninum tachyzoite serum (1:50) and MABs (20 µg/ml) for tachyzoite incubation were selected in several preliminary experiments. The incubation of Nc-Liv tachyzoites with hyperimmune anti-N. caninum tachyzoite serum caused a significant inhibition of tachyzoite host cell invasion compared to both non-treated tachyzoites and tachyzoites treated with rabbit pre-immune serum (average inhibition of 46.6%, P<0.005) (Fig. 3, panel  A) . When anti-rNcGRA7 MAB (1/24-12) was evaluated, a significant inhibition of tachyzoite invasion was also found compared to non-treated tachyzoites and non-specific MABtreated tachyzoites (average inhibition of 31.7%, P<0.005). Strong inhibition of tachyzoite invasion was observed compared to MAB buffer-treated tachyzoites (31.7% vs 15.7%) (P = 0.02) (Fig. 3, panel A) .
Regarding invasion inhibition assays with Nc-1SAG4 c tachyzoites, once again, hyperimmune anti-N. caninum tachyzoite serum significantly inhibited host cell invasion compared to non-treated and rabbit pre-immune serum-treated tachyzoites (average inhibition of 44.7%, P<0.005) (Fig. 3, panel  B) . Anti-rNcSAG4 MAB also showed a significant inhibition of host cell invasion compared to non-treated and non-specific MAB-treated tachyzoites (average inhibition of 20.0%, P<0.005) but not compared to MAB buffer-treated tachyzoites (20.0% vs 16.5%, P = 0.14) (Fig. 3, panel B) .
Discussion
Monoclonal antibodies were generated against two N. caninum recombinant proteins, rNcGRA7 and rNcSAG4, previously obtained and extensively described in earlier studies (Lally et al. 1997 , Fernández-García et al. 2006 , Aguado-Martínez et al. 2008 . High-quality MABs constitute a useful tool for characterising proteins of interest instead of classical polyclonal antibodies which could induce a non-specific background signal. Since MABs are Each additive was tested in three independent experiments; each experiment was performed in triplicate. Bars represent the means of the results and whiskers represent the standard deviation. Statistical significance is shown for anti-N. caninum tachyzoite hyperimmune serum compared to rabbit pre-immune serum and for anti-rNcGRA7 MAB or anti-rNcSAG4 MAB compared to non-specific MAB and MAB buffer only generated against a single epitope of an antigen, cross-reactions with other related Apicomplexa are usually diminished compared to polyclonal antibodies. Here, none of the MABs generated against either rNcGRA7 or rNcSAG4 showed cross-reactivity against T. gondii tachyzoites or bradyzoites.
Specific MABs binding a protein fraction of 33 kDa have been successfully isolated. This corresponds to the apparent molecular weight of the native NcGRA7 (Lally et al. 1997 , Schares et al. 1999 . The secondary 29-kDa antigenic fraction recognised by one of the MABs could correspond to the mature NcGRA7 without the signal peptide or with additional post-translational modifications. This finding was supported by the fact that NcGRA7 showed a predictive molecular weight of about 23 kDa after removing the signal peptide (Lally et al. 1997) and that NcGRA7-recombinant E. coli expresses two protein fractions of 33 and 24 kDa .
Immunofluorescent labelling of N. caninum tachyzoiteinfected cells by anti-rNcGRA7 MABs showed a reaction with cytoplasm structures in tachyzoites and with the tachyzoite surroundings and the vacuolar matrix. This labelling pattern suggests that NcGRA7 migrates from intracellular dense granules into the parasitophorous vacuole where it would interact with matrix components by developing oligomeric complexes through its hydrophobic domains. This is similar to the actions of its orthologue, TgGRA7 (Cesbron-Delauw 1994 , CesbronDelauw et al. 1996 , Bonhomme et al. 1998 , Fischer et al. 1998 , Braun et al. 2008 . Our NcGRA7 immunolocalisation studies confirm those previously described by others , Schares et al. 1999 , Vonlaufen et al. 2004 . The strong immunogenicity showed by GRA7 both in T. gondii (Neudeck et al. 2002 , Jongert et al. 2007 and N. caninum (Lally et al. 1996 , Aguado-Martínez et al. 2008 is easily explained by its target in the parasitophorous vacuole, which makes it very accessible to the host pathway of antigen processing (Fischer et al. 1998) . During the bradyzoite stage, NcGRA7 showed similar immunolocalisation to that observed on the tachyzoite stage confirming NcGRA7 expression in both stages , Schares et al. 1999 . Because no N. caninum mature cysts can be obtained in vitro, we do not know the pattern of NcGRA7 in this structure. However, previous studies have suggested that NcGRA7 is found in the cyst wall , Vonlaufen et al. 2004 . Immunogold electron microscopy could be applied on cyst-containing intermediate host brain tissues in order to investigate this issue.
The inhibition invasion assay with anti-rNcGRA7 MAB showed a statistically significant, but not a complete, inhibition of tachyzoite invasion into host cells as compared to control groups. These results suggest that NcGRA7 contributes to invasion, which is likely a complex process involving many proteins. This conclusion would be in agreement with the normal function assigned to GRA proteins as they are targeted to the vacuolar space very shortly after invasion . Other authors have also found an NcGRA7-related inhibition effect on invasion (Augustine et al. 1999 , Cho et al. 2005 thus supporting this idea.
Finally, the specific and intense signal conferred by antirNcGRA7 MABs renders them strong candidates for use in developing a competitive ELISA for diagnosis of N. caninum infection. This technique would be especially useful in dogs, for which current serological techniques lack the sensitivity and specificity of those used in bovines (Silva et al. 2007 , Ghalmi et al. 2009 ).
NcSAG4 protein is a surface antigen specifically expressed in the bradyzoite stage (Fernández-García et al. 2006) . Similar to other specific-bradyzoite proteins in T. gondii (Di Cristina et al. 2004) , its immunogenicity seems to be reduced when compared to secreted/excreted proteins (Aguado- Martínez et al. 2008 Martínez et al. , 2009a ). This reduction serves as an immune evasion mechanism, allowing it to persist in the host (Kim and Boothroyd 2005) . The anti-rNcSAG4 MAB, developed in the present study, specifically recognised a 15-16 kDa band in the tachyzoite-bradyzoite extract but not in the tachyzoite extract confirming its stage-specificity expression, in concordance with the predictive molecular weight of native NcSAG4, 18.4 kDa (Fernández-García et al. 2006) .
The labelling of the native NcSAG4 on bradyzoite-infected cell cultures by immunofluorescence was more difficult to achieve. We isolated only one positive hybridoma clone, which produced a weak signal. Possible reasons for poor MAB binding could be a naturally low immunogenicity of NcSAG4 and/or no pure bradyzoites obtained in vitro. However, these reasons are unlikely because NcSAG4 has previously proven to be immunogenic, and is expressed early during tachyzoite-to-bradyzoite conversion (Fernández-García et al. 2006 , Aguado-Martínez et al. 2008 . A more reasonable explanation could be alternative folding of rNcSAG4, against which the MAB has been developed, compared to the conformation of native NcSAG4. Alternatively, NcSAG4 could be a minor protein compared with other more abundant proteins. This latter explanation is reasonable because Nc-1SAG4 c transgenic tachyzoites (Marugán-Hernández et al. submitted) were specifically bound by anti-rNcSAG4 MAB with a surface pattern.
No invasion inhibition was detected using anti-rNcSAG4 MAB. This result is not surprising because NcSAG4 is not expressed in wild-type tachyzoites. Therefore, no involvement in the tachyzoite invasion is expected. Little is known about the functions of bradyzoite-specific proteins in T. gondii. Some proteins have been related to tissue cyst formation and maintenance or to reactivation in the intestine Boothroyd 2005, Kim et al. 2007) , whereas others have suggested its involvement in the merozoite phase of the life cycle in definitive hosts just after bradyzoite ingestion (Schwarz et al. 2005) . Research on adhesion and invasion capacity of NcSAG4 and other N. caninum bradyzoite-specific proteins to intestinal epithelium should be carried out in the future.
In summary, monoclonal antibodies against the immunogenic, dense granule protein rNcGRA7 and the specific brad-yzoite protein rNcSAG4 were successfully developed. AntirNcGRA7 MABs confirmed the apparent molecular weight of native NcGRA7, the shared expression between both asexual stages and the immunolocalisation in N. caninum-infected cells. Moreover, anti-NcGRA7 MAB partially inhibited the invasion process. The anti-rNcSAG4 MAB confirmed the bradyzoite-specific expression of this protein. Although this protein is not involved in the tachyzoite invasion, further studies concerning its role in the bradyzoite attachment to the host cell surface and the evasion of host immune system should be carried out.
